CYP51-mediated cholesterol biosynthesis is required for the proliferation of CD4+ T cells in Sjogren's syndrome

Clin Exp Med. 2023 Sep;23(5):1691-1711. doi: 10.1007/s10238-022-00939-5. Epub 2022 Nov 21.

Abstract

CYtochrome P450, family 51 (CYP51) is an important enzyme for de novo cholesterol synthesis in mammalian cells. In the present study, we found that the expression of CYP51 positively correlated with CD4+ T cell activation both in vivo and in vitro. The addition of ketoconazole, a pharmacological inhibitor of CYP51, prevented the proliferation and activation of anti-CD3/CD28-expanded mouse CD4+ T cells in a dose-dependent fashion. Liquid chromatography-tandem mass spectrometry indicated an increase in levels of lanosterol in T cells treated with ketoconazole during activation. Ketoconazole-induced blockade of the cholesterol synthesis pathway also caused Sterol regulatory element binding protein 2 (SREBP2) activation in CD4+ T cells. Additionally, ketoconazole treatment elicited an integrated stress response in T cells that up-regulated activating transcription factor 4 (ATF4) and DNA-damage inducible transcript 3 (DDIT3/CHOP) at the translational level. Furthermore, treatment with ketoconazole significantly decreased the amount of CD4+ T cells infiltrating lesions in the submandibular glands of NOD/Ltj mice. In summary, our results suggest that CYP51 plays an essential role in the proliferation and survival of CD4+ T cells, which makes ketoconazole an inhibitor of CD4+ T cell proliferation and of the SS-like autoimmune response through regulating the biosynthesis of cholesterol and inducing the integrated stress response.

Keywords: CD4+ T cell; CYP51; Integrated stress response; Ketoconazole; Sjogren’s syndrome.

MeSH terms

  • Animals
  • CD4-Positive T-Lymphocytes / metabolism
  • Cell Proliferation
  • Cholesterol
  • Cytochrome P-450 Enzyme System / chemistry
  • Cytochrome P-450 Enzyme System / metabolism
  • Humans
  • Ketoconazole* / pharmacology
  • Mammals / metabolism
  • Mice
  • Mice, Inbred NOD
  • Sjogren's Syndrome*
  • T-Lymphocytes / metabolism

Substances

  • Cholesterol
  • Cytochrome P-450 Enzyme System
  • Ketoconazole
  • CYP51A1 protein, human